Please wait a minute...
European Journal of Gynaecological Oncology  2016, Vol. 37 Issue (4): 474-477    DOI: 10.12892/ejgo3093.2016
Original Research Previous articles | Next articles
Comparison of the histopathological results of the endometrial thickness detected by transvaginal ultrasound of symptomatic and asymptomatic postmenopausal women
İ. Ulu1, *(), A. Çelik2, B. Haliloğlu2, E. İlter2, A. Midi3
1 Department of Obstetrics and Gyneacology, Ümraniye Medical and Research Hospital, Istanbul, Turkey
2 Department of Obstetrics and Gyneacology, Maltepe University Hospital, Istanbul, Turkey
3 Department of Pathology, Maltepe University Hospital, Istanbul, Turkey
Download:  PDF(93KB)  ( 42 )
Export:  BibTeX | EndNote (RIS)      
Abstract  
Objective: The purpose of the study was to assess the reliability of transvaginal ultrasound (TVUSG) in endometrial pathologies by comparing the ultrasonographic and histopathologic findings in symptomatic and asymptomatic postmenopausal women. Materials and Methods: In this retrospective study the data of 129 postmenopausal women that underwent dilatation and curettage was reviewed by dividing them two groups as symptomatic and asymptomatic. Symptomatic group was divided into subgroups according to the value of endometrial thickness obtained by TVUSG. Results: Among all subjects the cancer rate was found statistically 3.043 times higher in patients with the endometrial thickness of 15 mm and greater and atrophic endometrium rate was 75% in patients with the endometrial thickness of less than five mm. Endometrial thickness was found significantly higher in cancer patients than the others (p < 0.05). Among the patients with endometrial thickness of 15 mm and greater, the cancer rate was found higher in symptomatic group than in the asymptomatic group. The cancer rate was found statistically higher in patients with bleeding compared to asymptomatic ones with the endometrial thickness between 5-14.99 mm (p < 0.05). Cancer was not detected in any of the symptomatic patients with the endometrial thickness of less than five mm. Conclusion: Postmenopausal patients with the symptom of bleeding should undergo detailed gynecological and ultrasonographic examination. The authors believe that this study may be a strong support to the success of TVUSG as a screening method in both symptomatic and asymptomatic postmenopausal women. Furthermore if the patient is symptomatic with a thick endometrium, to exclude the malignancy, endometrial biopsy must be performed.
Key words:  Postmenopausal bleeding      Transvaginal ultrasonography      Endometrial thickness      Endometrium cancer      Menopause     
Published:  10 August 2016     
*Corresponding Author(s):  İ. ULU     E-mail:  dripekulu@gmail.com

Cite this article: 

İ. Ulu, A. Çelik, B. Haliloğlu, E. İlter, A. Midi. Comparison of the histopathological results of the endometrial thickness detected by transvaginal ultrasound of symptomatic and asymptomatic postmenopausal women. European Journal of Gynaecological Oncology, 2016, 37(4): 474-477.

URL: 

https://ejgo.imrpress.com/EN/10.12892/ejgo3093.2016     OR     https://ejgo.imrpress.com/EN/Y2016/V37/I4/474

[1] Rossella E. Nappi, Nicoletta Biglia, Ettore Cicinelli, Tiziana Di Paolantonio, Stefano Luisi, Massimo Stomati, Paola Villa, on behalf of the EVES study investigators. The European Vulvovaginal Epidemiological Survey (EVES) in Italy. Impact of vulvovaginal atrophy on the quality of life and sexual function in breast cancer survivors[J]. European Journal of Gynaecological Oncology, 2021, 42(1): 38-44.
[2] T. Uehara, A. Mitsuhashi, M. Shozu. The impact of pre-existing polycystic ovary syndrome on endometrial cancer recurrence[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 668-674.
[3] Marcin Jedryka, Agnieszka Chrobak, Anna Chelmonska-Soyta, Daria Fijalkowska, Rafal Matkowski. Decreased expression of estrogen receptors alpha and beta in peripheral blood lymphocytes from the endometrial cancer patients and women with endometriosis[J]. European Journal of Gynaecological Oncology, 2020, 41(3): 375-379.
[4] Guolin Liu, Rui Zhang. Postmenopausal recurrent retrovaginal extramural gastrointestinal stromal tumor: a case report[J]. European Journal of Gynaecological Oncology, 2020, 41(3): 473-476.
[5] A. Daniilidis, D. Balaouras, D. Chitzios, Ü. Kalkan, A. Mamopoulos, E. Assimakopoulos. Can the measurement of endometrial thickness by transvaginal ultrasound be used for the prediction of endometrial cancer in asymptomatic post-menopausal women? A systematic review of the literature[J]. European Journal of Gynaecological Oncology, 2019, 40(5): 752-758.
[6] D.J. Liu, X.H. Bi, Y.X Yang. Transvaginal ultrasound intrauterine echo flow resistance index as predictor of lymphovascular space invasion in endometrioid adenocarcinoma[J]. European Journal of Gynaecological Oncology, 2019, 40(4): 652-655.
[7] K. Plagens–Rotman, M. Chuchracki, M. Piskorz–Szymendera, M. Połocka–Molińska, I. Miechowicz. Reproductive factors and the endometrial cancer morbidity[J]. European Journal of Gynaecological Oncology, 2019, 40(3): 431-436.
[8] L. Wang, A. Yao, A. Zhang, P. Qu. Sertoli-Leydig cell tumor characterized by hyperestrogenism in a postmenopausal woman: a case report and review of the literature[J]. European Journal of Gynaecological Oncology, 2019, 40(3): 502-505.
[9] K. Jakopič Maček, Š. Bricl, I. Verdenik, B. Kobal. Role of transvaginal ultrasound in finding endometrial cancer in postmenopausal women with or without bleeding[J]. European Journal of Gynaecological Oncology, 2019, 40(1): 60-64.
[10] S. Stanosz, J. von Mach Szczypiński, A. Fogel, E. Sowińska-Przepiera, J. Kościuszkiewicz, E. Żochowska, A. Syrenicz. Concentration of serotonin in perimenopausal women with ductal breast cancer and polycystic ovary syndrome[J]. European Journal of Gynaecological Oncology, 2018, 39(6): 884-888.
[11] M.O. Matsuya, K. Sugihara, C. Yaguchi, H. Itoh, H. Kitamura, N. Kanayama, K. Arahori. Leiomyomatosis peritonealis disseminata with aromatase cytochrome P450 expression in a postmenopausal woman: a case study with literature review[J]. European Journal of Gynaecological Oncology, 2018, 39(5): 838-842.
[12] D.H. Zou, X.M. He, B. Chen, X.H. Xu, X.P. Zhang, J.F. Ni, W.M. Mao. Expression and association of reproductive hormones and receptors in postmenopausal patients with breast cancer[J]. European Journal of Gynaecological Oncology, 2017, 38(5): 727-732.
[13] R.R. Aapkes, R.A.K. Samlal. A case of delayed diagnosis of endometrial carcinoma due to a uterus didelphys[J]. European Journal of Gynaecological Oncology, 2017, 38(5): 810-812.
[14] H.C. Ozcan, O. Balat, M.G. Ugur, S. Kul, Z. Bozdag, S. Sucu, I. Keklikcioglu. The management of adnexal masses in premenopausal patients: a ten-year retrospective study at a single center[J]. European Journal of Gynaecological Oncology, 2017, 38(3): 372-377.
[15] G.M. Gressel, N. Buza, L. Pal. Ovarian Sertoli-Leydig cell tumors: a single institution experience and review of the literature[J]. European Journal of Gynaecological Oncology, 2017, 38(2): 214-220.
No Suggested Reading articles found!